Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10

D-0387-2025

April 14, 2025

Class II

Product summary

Firm
Breckenridge Pharmaceutical, Inc
Event
Event 96707
Status
Ongoing
Classification
Class II
Quantity
16,473 bottles
Official record key
drug-enforcement:D-0387-2025

Official wording

Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Code information: Lot # 240987C, exp. date 04/2027 241014C, exp. date 04/2027

Distribution pattern: US Nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Nitrosamine Drug Substance Related Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations